SCHEDULE: Thrive Capital Funds Adjust Oscar Health Stake

Multiple Thrive Capital entities and Joshua Kushner have updated their beneficial ownership filings for Oscar Health, Inc., detailing share transfers and distributions.

Summary

• This filing is an amendment (Amendment No. 4) to a Schedule 13D concerning Oscar Health, Inc. (the "Company").
• It details changes in beneficial ownership of Class A and Class B common stock by various Thrive Capital entities and Joshua Kushner.
• The filing reports on share transfers between Thrive Capital funds and distributions of Class A common stock to limited partners and general partners.
• As of the filing date, Joshua Kushner beneficially owns 37,525,451 shares of Class A Common Stock, representing 12.1% of the class.
• The total outstanding Class A Common Stock was reported as 273,469,000 shares as of July 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reflecting routine ownership updates and share transfers rather than significant new strategic information or performance indicators.

Positives

• The filing provides transparency regarding significant beneficial ownership changes, which is crucial for market participants.
• The detailed breakdown of shareholdings across various Thrive Capital entities offers clarity on the investment structure.

Negatives

• The filing does not contain any financial performance data or strategic updates for Oscar Health, Inc., limiting its insight into the company's operational health.
• The complex web of fund structures and inter-fund transfers can obscure the ultimate beneficial ownership and control.

Risks

• The conversion of Class B common stock to Class A common stock could occur on the date seven years from the IPO prospectus or upon certain events, potentially altering voting power and ownership percentages.
• Fluctuations in the market price of Oscar Health's Class A Common Stock could impact the value of the holdings reported.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from the company. It primarily details past and present ownership structures and transactions.

Industry Context

StockSavvy.ai notes that Schedule 13D filings are common for significant investors accumulating or adjusting stakes in public companies. This filing indicates ongoing strategic management of holdings by Thrive Capital entities within the health insurance technology sector.

Related Party Transactions

• Transfers of Class B Common Stock between Thrive Capital funds (Thrive II, Thrive III, Claremount TW) to Thrive VII Growth and Claremount VII in exchange for Class A Common Stock.
• Distributions of Class A Common Stock from Thrive II, Thrive III, and Claremount TW to their respective limited partners and general partners.
• Distributions of Class A Common Stock from Thrive Partners II GP, LLC and Thrive Partners III GP, LLC to their members.

Stakeholder Impact

• Shareholders: Increased transparency on significant ownership stakes and potential shifts in voting power.
• Management: Awareness of the substantial holdings by Thrive Capital entities.
• Creditors: No direct impact indicated by this ownership filing.

Next Steps

• Continued monitoring of subsequent amendments to Schedule 13D for any further changes in beneficial ownership.
• Observation of Oscar Health, Inc.'s performance and strategic developments as reported in its regular SEC filings.

Key Dates

Keywords

Oscar Health, Thrive Capital, Joshua Kushner, Schedule 13D, Beneficial Ownership, Class A Common Stock, Class B Common Stock, Share Transfer